Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
University Hospital Heidelberg
Baptist Health South Florida
Memorial Sloan Kettering Cancer Center
Monteris Medical
Essen Biotech
Essen Biotech
M.D. Anderson Cancer Center
NRG Oncology
Turning Point Therapeutics, Inc.
Hadassah Medical Organization
Emory University
Assistance Publique - Hôpitaux de Paris
Plus Therapeutics
University of California, San Francisco
Henry Ford Health System
Thomas Jefferson University
Assistance Publique - Hôpitaux de Paris
UMC Utrecht